Rangeley Capital’s STAAR Surgical STAA Stock Holding History

Rangeley Capital’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,000	Closed	-$269K	–	158
2025 Q3	$269K	Buy	+10,000	New	+$238K	0.23%	75

Other funds holding STAA

Broadwood Capital New York $1.91B AUM 44.39% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Yunqi Capital Hong Kong $125M AUM 13.99% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Rangeley Capital's STAA Position: Q4 2025 in Review

Rangeley Capital sold out of STAAR Surgical (STAA) in Q4 2025, closing a stake of 10,000 shares — an estimated $269K sold.

Rangeley Capital first reported a position in STAA in Q3 2025 and held it in 1 quarter. The position peaked at $269K in Q3 2025. 201 funds tracked by Wall St. Rank hold STAA as of Q4 2025.

Rangeley Capital reported no remaining STAAR Surgical position as of Q4 2025 after selling out during the quarter.
Rangeley Capital sold 10,000 STAAR Surgical shares in Q4 2025, an estimated $269K.
Rangeley Capital first reported a position in STAAR Surgical in Q3 2025 and held it in 1 quarter.
Rangeley Capital's STAAR Surgical position peaked at $269K in Q3 2025.
201 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2025.

Based on Rangeley Capital's 13F filing for Q4 2025, filed 17 Feb 2026.